Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid Tumours

NCT03315091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumours

Interventions

DRUG: Treatment A - AZD1775 administered under fasted conditions
DRUG: Treatment B - AZD1775 administered under fed conditions.

Sponsor

AstraZeneca

Collaborators

[object Object]